Martin Distel

Associate Professor

University of Utah

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Martin Distel is an Associate Professor at the University of Utah, United States. His research focuses on cancer biology and pharmacology, particularly the mechanisms of angiogenesis, photopharmacology, and the development of novel inhibitors targeting key cellular pathways. Recent articles authored by Dr. Distel explore various aspects of tumor biology using zebrafish models and iPSCs, aiming to optimize therapeutic strategies against metastatic diseases.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (10)

Evon Poon

Institute of Cancer Research

UNITED KINGDOM

View details

Rainer Leitgeb

Associate Professor

Medical University of Vienna

AUSTRIA

View details

Peter Andrews

University of Sheffield

UNITED KINGDOM

View details

Sebastian Granitzer

Medical University of Vienna

AUSTRIA

View details

Rene Werkmeister

Assoc. Prof.

Medical University of Vienna

AUSTRIA

View details

Marco Andreana

Medical University of Vienna

AUSTRIA

View details

Oliver Pusch

Associate Professor

Medical University of Vienna

AUSTRIA

View details

Wolfgang Drexler

Honorary Distinguished Professor

Cardiff University

UNITED KINGDOM

View details

Anestis Tsakiridis

UNITED KINGDOM

View details

Ivana Barbaric

Lecturer

University of Sheffield

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Martin Distel

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Multimodal Investigation of Angiogenesis and Its Prevention by Small Compounds in a Zebrafish Cancer Model

zHORSE as an optogenetic zebrafish strain for precise spatiotemporal control over gene expression during development

Precise photopharmacological eradication of metastatic tumor cells.

A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations

BRAFV600E induces key features of LCH in iPSCs with cell type-specific phenotypes and drug responses

Hiding in plain sight: Optimizing topoisomerase IIα inhibitors into Hsp90β selective binders

Perfluorodecanoic acid (PFDA) increases oxidative stress through inhibition of mitochondrial β-oxidation

First dual inhibitors of human topoisomerase IIα and Hsp90 C-terminal domain inhibit the growth of Ewing sarcoma in vitro and in vivo

Exploration and optimisation of structure-activity relationships of new triazole-based C-terminal Hsp90 inhibitors towards in vivo anticancer potency

Senescence-associated ß-galactosidase staining over the lifespan differs in a short- and a long-lived fish species

Collaborators (10)

Evon Poon

Rainer Leitgeb

Peter Andrews

Sebastian Granitzer

Rene Werkmeister

Marco Andreana

Oliver Pusch

Wolfgang Drexler

Anestis Tsakiridis

Ivana Barbaric

Make your next move.